Baynes Roy D.

CIK 00016807396 companiesAUSTIN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001680739

Recent Transactions

50 trades

Award
Natera, Inc.$NTRA
Common Stock
2026-06-26+1,571→ 20,083 total
Award
Natera, Inc.$NTRA
Common Stock
2026-06-26+75→ 20,158 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-06-12$21.38/sh+4,500→ 46,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-06-12$50.00/sh−4,500→ 41,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-06-12−4,500→ 0 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-19+4,000→ 41,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-19+12,000→ 12,000 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2026-05-15+31,250→ 31,250 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-05$18.27/sh+4,500→ 42,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-05$46.65/sh−4,500→ 37,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-05−4,500→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-01$6.82/sh+9,750→ 47,250 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-01$44.22/sh−9,750→ 37,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-01−9,750→ 9,750 total
Award
Natera, Inc.$NTRA
Common Stock
2026-04-24+83→ 18,512 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$17.94/sh+8,000→ 45,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$15.43/sh+9,000→ 54,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$18.27/sh+4,500→ 59,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$21.38/sh+4,500→ 63,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$17.11/sh+6,750→ 70,250 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$41.07/sh−26,000→ 44,250 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$42.12/sh−6,750→ 37,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-14−8,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-14−9,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-14−4,500→ 4,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-14−4,500→ 4,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-14−6,750→ 6,750 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-06$26.52/sh+10,000→ 47,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-06$33.00/sh−10,000→ 37,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-04-06−10,000→ 0 total
Award
Eikon Therapeutics, Inc.$EIKN
Stock Option (Right to Buy)
2026-03-02+134,088→ 134,088 total
Award
Natera, Inc.$NTRA
Common Stock
2026-01-30+70→ 18,429 total
Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-20−600→ 0 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-20$41.19/sh+7,068→ 26,027 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$224.89/sh−1,884→ 18,359 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-20$40.93/sh+600→ 18,959 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$220.14/sh−1,184→ 24,843 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$223.90/sh−1,900→ 20,243 total
Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-20−7,068→ 0 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$221.81/sh−900→ 23,943 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$222.90/sh−1,800→ 22,143 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$213.47/sh−1,250→ 22,221 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$216.07/sh−2,135→ 18,359 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-19$40.93/sh+5,112→ 23,471 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$214.79/sh−1,727→ 20,494 total
Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-19−5,112→ 600 total
Award
Natera, Inc.$NTRA
Common Stock
2025-10-31+93→ 18,359 total
Award
Natera, Inc.$NTRA
Common Stock
2025-07-25+108→ 18,266 total
Award
Natera, Inc.$NTRA
Common Stock
2025-06-27+2,143→ 18,158 total
Award
Aardvark Therapeutics, Inc.$AARD
Stock Option (right to buy)
2025-06-11+30,508→ 30,508 total

Companies

Recent Filings

Address

C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100

AUSTIN, TX, 78753

View on SEC.gov